Skip to main content

Advertisement

Log in

Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathy

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Purpose

Apical wall thickening with an “ace-of-spades” configuration is a unique sign of apical hypertrophic cardiomyopathy (AHCM). We investigated spade-shaped FDG uptake around the left ventricular apex (SSUA) incidentally found in routine oncological FDG PET.

Methods

Cases showing SSUA were selected based on retrospective review. The pattern or intensity of SSUA was compared with the results of electrocardiogram (ECG), echocardiography, and stress myocardial perfusion SPECT. The diagnosis of ACHM was based on the presence of giant negative T wave in ECG, thickness of spade-shaped hypertrophy in the apex in echocardiography, and increased tracer uptake in the apex in rest SPECT.

Results

Among the 34 patients in 36 PET scans showing SSUA, SSUA was weak in 17 and intense in 17. There were isolated SSUA (n = 29) and SSUA with diffuse or other focal left ventricular uptake (n = 5). Three patients with the latter uptake pattern turned out to have coexistence of AHCM and asymmetric septal hypertrophy. Of the 16 SSUA-positive patients who underwent echocardiography, 13 (81%) were diagnosed as AHCM and the remaining 3 were regarded as borderline AHCM (apical wall thickness, 14–15 mm). There were 16 patients with SSUA who also underwent PET scans after the study period among which 11 (69%) had persistent SSUA in the follow-up PET. In the remaining 5, follow-up PET scans showed diffuse left ventricular uptake and SSUA was barely visible. The intensity of SSUA was significantly or marginally associated with giant negative T wave (p < 0.01), apical asynergy (p = 0.08), and impaired coronary flow reserve (p < 0.05). There were no other factors correlated with the pattern or intensity of SSUA.

Conclusion

SSUA incidentally found in oncological FDG PET appeared to be associated with AHCM, especially in ischemic conditions. The moderate repeatability of SSUA was probably due to obscurity by physiological uptake.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381:242–55.

    Article  PubMed  Google Scholar 

  2. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J. 1976;17:611–29.

    Article  CAS  PubMed  Google Scholar 

  3. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol. 1979;44:401–12.

    Article  CAS  PubMed  Google Scholar 

  4. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:1027–35.

    Article  CAS  PubMed  Google Scholar 

  5. Cannon RO 3rd, Dilsizian V, O’Gara PT, Udelson JE, Schenke WH, Quyyumi A, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation. 1991;83:1660–7.

    Article  PubMed  Google Scholar 

  6. Cianciulli TF, Saccheri MC, Masoli OH, Redruello MF, Lax JA, Morita LA, et al. Myocardial perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy. J Nucl Cardiol. 2009;16:391–5.

    Article  PubMed  Google Scholar 

  7. Minamimoto R, Morooka M, Miyata Y, Ito K, Okasaki M, Hara H, et al. Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening. Ann Nucl Med. 2013;27:572–80.

    Article  PubMed  Google Scholar 

  8. Fukuchi K, Ohta H, Matsumura K, Ishida Y. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol. 2007;80:3–11.

    Article  CAS  PubMed  Google Scholar 

  9. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39:638–45.

    Article  PubMed  Google Scholar 

  10. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol. 1990;15:83–90.

    Article  CAS  PubMed  Google Scholar 

  11. Hashimoto J, Nakahara T, Bai JM, Kitamura N, Kasamatsu T, Kubo A. Preoperative risk stratification with myocardial perfusion imaging in intermediate and low-risk non-cardiac surgery. Circ J. 2007;71:1395–400.

    Article  PubMed  Google Scholar 

  12. Sakamoto T. Apical hypertrophic cardiomyopathy (apical hypertrophy): an overview. J Cardiol. 2001;37(Suppl 1):161–78.

    PubMed  Google Scholar 

  13. Koga Y, Katoh A, Matsuyama K, Ikeda H, Hiyamuta K, Toshima H, et al. Disappearance of giant negative T waves in patients with the Japanese form of apical hypertrophy. J Am Coll Cardiol. 1995;26:1672–8.

    Article  CAS  PubMed  Google Scholar 

  14. Olearczyk B, Gollol-Raju N, Menzies DJ. Apical hypertrophic cardiomyopathy mimicking acute coronary syndrome: a case report and review of the literature. Angiology. 2008;59:629–31.

    Article  PubMed  Google Scholar 

  15. Kebed KY, Al Adham RI, Bishu K, Askew JW, Klarich KW, Araoz PA, et al. Evaluation of apical subtype of hypertrophic cardiomyopathy using cardiac magnetic resonance imaging with gadolinium enhancement. Am J Cardiol. 2014;114:777–82.

    Article  PubMed  Google Scholar 

  16. Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol. 2000;31:988–98.

    Article  CAS  PubMed  Google Scholar 

  17. Mirtschink P, Krek W. Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart disease. Biochim Biophys Acta. 2016;1863:1822–8.

    Article  CAS  PubMed  Google Scholar 

  18. Nienaber CA, Gambhir SS, Mody FV, Ratib O, Huang SC, Phelps ME, et al. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation. 1993;87:1580–90.

    Article  CAS  PubMed  Google Scholar 

  19. Okayama S, Kawata H, Sung JH, Okada S, Nishida T, Onoue K, et al. Dual-single photon emission computed tomography and contrast-enhanced magnetic resonance imaging to evaluate dissimilar features of apical hypertrophic cardiomyopathy. Cardiol J. 2010;17:306–11.

    PubMed  Google Scholar 

  20. Tadamura E, Tamaki N, Matsumori A, Magata Y, Yonekura Y, Nohara R, et al. Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med. 1996;37:572–7.

    CAS  PubMed  Google Scholar 

  21. Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016;23:244–52.

    Article  PubMed  Google Scholar 

  22. Scholtens AM, Verberne HJ, Budde RP, Lam MG. Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in (1)(8)F-FDG PET imaging. J Nucl Med. 2016;57:568–73.

    Article  PubMed  Google Scholar 

  23. Perrone-Filardi P, Bacharach SL, Dilsizian V, Panza JA, Maurea S, Bonow RO. Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy. Am J Cardiol. 1993;72:199–204.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank colleagues at the Departments of Diagnostic Radiology and Cardiology involved in ECG, echocardiography, myocardial perfusion scan, and coronary computed tomography angiographic scan for this study. No grant support was received for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tadaki Nakahara.

Ethics declarations

Conflict of interest

The authors report no relationships that could be construed as a conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katagiri, M., Nakahara, T., Murata, M. et al. Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathy. Ann Nucl Med 31, 399–406 (2017). https://doi.org/10.1007/s12149-017-1167-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-017-1167-2

Keywords

Navigation